Calloway Nathaniel
SEC CIK 1952771 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LFCR | LIFECORE BIOMEDICAL, INC. DE | Dir | 58.1K | — | — | 4 | 2023-06-01 | 2024-07-08 |
Most active insiders at LFCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Salus Thomas D. | Chief Legal, Administration | — | — |
| 2 | Johnson Paul Harold | Dir | — | — |
| 3 | Josephs Paul | CEO, Dir | — | — |
| 4 | Antunes Humberto Calheiros | Dir | — | — |
| 5 | Korenberg Matthew E | Dir | — | — |
| 6 | Kiper Christopher S | Dir, 10% | — | — |
| 7 | Aryeh Jason | Dir | — | — |
| 8 | Schechter Joshua | Dir | — | — |
| 9 | HOUDE LOVAS KATRINA | Dir | — | — |
| 10 | OBUS NELSON | Dir | — | — |
Calloway Nathaniel made no open-market trades at LFCR in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-10 | 2024-07-08 | LFCR | LIFECORE BIOMEDICAL, INC. DE | Calloway Nathaniel | Dir | A - Grant | — | +30.0K | 58.1K | +107% | — | |
| D | 2024-02-02 | 2024-02-01 | LFCR | LIFECORE BIOMEDICAL, INC. DE | Calloway Nathaniel | Dir | M - OptEx | — | +3,981 | 28.1K | +17% | — |
| D | 2024-01-10 | 2024-01-09 | LFCR | LIFECORE BIOMEDICAL, INC. DE | Calloway Nathaniel | Dir | M - OptEx | — | +5,906 | 24.1K | +32% | — |
| 2023-06-05 | 2023-06-01 | LFCR | LIFECORE BIOMEDICAL, INC. DE | Calloway Nathaniel | Dir | A - Grant | — | +18.2K | 18.2K | New | — |
Purchase Sale Sale after option exercise All abbreviations